Report Detail

Pharma & Healthcare Global Anti-inflammatory Drugs Market Insights and Forecast to 2026

  • RnM4153305
  • |
  • 24 August, 2020
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Anti-inflammatory Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-inflammatory Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Anti-inflammatory Drugs market is segmented into
Aspirin
Ibuprofen
Naproxen
Celecoxib
Others

Segment by Application, the Anti-inflammatory Drugs market is segmented into
Skin Rashes
Chronic Arthritis
Other

Regional and Country-level Analysis
The Anti-inflammatory Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-inflammatory Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-inflammatory Drugs Market Share Analysis
Anti-inflammatory Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-inflammatory Drugs business, the date to enter into the Anti-inflammatory Drugs market, Anti-inflammatory Drugs product introduction, recent developments, etc.

The major vendors covered:
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen
Bayer
Novacap
Kopran Ltd.


1 Study Coverage

  • 1.1 Anti-inflammatory Drugs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Anti-inflammatory Drugs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Anti-inflammatory Drugs Market Size Growth Rate by Type
    • 1.4.2 Aspirin
    • 1.4.3 Ibuprofen
    • 1.4.4 Naproxen
    • 1.4.5 Celecoxib
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Anti-inflammatory Drugs Market Size Growth Rate by Application
    • 1.5.2 Skin Rashes
    • 1.5.3 Chronic Arthritis
    • 1.5.4 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Anti-inflammatory Drugs Market Size, Estimates and Forecasts
    • 2.1.1 Global Anti-inflammatory Drugs Revenue 2015-2026
    • 2.1.2 Global Anti-inflammatory Drugs Sales 2015-2026
  • 2.2 Global Anti-inflammatory Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Anti-inflammatory Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Anti-inflammatory Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Anti-inflammatory Drugs Competitor Landscape by Players

  • 3.1 Anti-inflammatory Drugs Sales by Manufacturers
    • 3.1.1 Anti-inflammatory Drugs Sales by Manufacturers (2015-2020)
    • 3.1.2 Anti-inflammatory Drugs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Anti-inflammatory Drugs Revenue by Manufacturers
    • 3.2.1 Anti-inflammatory Drugs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Anti-inflammatory Drugs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Anti-inflammatory Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Anti-inflammatory Drugs Revenue in 2019
    • 3.2.5 Global Anti-inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Anti-inflammatory Drugs Price by Manufacturers
  • 3.4 Anti-inflammatory Drugs Manufacturing Base Distribution, Product Types
    • 3.4.1 Anti-inflammatory Drugs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Anti-inflammatory Drugs Product Type
    • 3.4.3 Date of International Manufacturers Enter into Anti-inflammatory Drugs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Anti-inflammatory Drugs Market Size by Type (2015-2020)
    • 4.1.1 Global Anti-inflammatory Drugs Sales by Type (2015-2020)
    • 4.1.2 Global Anti-inflammatory Drugs Revenue by Type (2015-2020)
    • 4.1.3 Anti-inflammatory Drugs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Anti-inflammatory Drugs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Anti-inflammatory Drugs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Anti-inflammatory Drugs Revenue Forecast by Type (2021-2026)
    • 4.2.3 Anti-inflammatory Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Anti-inflammatory Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Anti-inflammatory Drugs Market Size by Application (2015-2020)
    • 5.1.1 Global Anti-inflammatory Drugs Sales by Application (2015-2020)
    • 5.1.2 Global Anti-inflammatory Drugs Revenue by Application (2015-2020)
    • 5.1.3 Anti-inflammatory Drugs Price by Application (2015-2020)
  • 5.2 Anti-inflammatory Drugs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Anti-inflammatory Drugs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Anti-inflammatory Drugs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Anti-inflammatory Drugs Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Anti-inflammatory Drugs by Country
    • 6.1.1 North America Anti-inflammatory Drugs Sales by Country
    • 6.1.2 North America Anti-inflammatory Drugs Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Anti-inflammatory Drugs Market Facts & Figures by Type
  • 6.3 North America Anti-inflammatory Drugs Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Anti-inflammatory Drugs by Country
    • 7.1.1 Europe Anti-inflammatory Drugs Sales by Country
    • 7.1.2 Europe Anti-inflammatory Drugs Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Anti-inflammatory Drugs Market Facts & Figures by Type
  • 7.3 Europe Anti-inflammatory Drugs Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Anti-inflammatory Drugs by Region
    • 8.1.1 Asia Pacific Anti-inflammatory Drugs Sales by Region
    • 8.1.2 Asia Pacific Anti-inflammatory Drugs Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Anti-inflammatory Drugs Market Facts & Figures by Type
  • 8.3 Asia Pacific Anti-inflammatory Drugs Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Anti-inflammatory Drugs by Country
    • 9.1.1 Latin America Anti-inflammatory Drugs Sales by Country
    • 9.1.2 Latin America Anti-inflammatory Drugs Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Anti-inflammatory Drugs Market Facts & Figures by Type
  • 9.3 Central & South America Anti-inflammatory Drugs Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Anti-inflammatory Drugs by Country
    • 10.1.1 Middle East and Africa Anti-inflammatory Drugs Sales by Country
    • 10.1.2 Middle East and Africa Anti-inflammatory Drugs Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Anti-inflammatory Drugs Market Facts & Figures by Type
  • 10.3 Middle East and Africa Anti-inflammatory Drugs Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Roche
    • 11.1.1 Roche Corporation Information
    • 11.1.2 Roche Description and Business Overview
    • 11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Roche Anti-inflammatory Drugs Products Offered
    • 11.1.5 Roche Related Developments
  • 11.2 Abbott Laboratories
    • 11.2.1 Abbott Laboratories Corporation Information
    • 11.2.2 Abbott Laboratories Description and Business Overview
    • 11.2.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Abbott Laboratories Anti-inflammatory Drugs Products Offered
    • 11.2.5 Abbott Laboratories Related Developments
  • 11.3 Johnson & Johnson
    • 11.3.1 Johnson & Johnson Corporation Information
    • 11.3.2 Johnson & Johnson Description and Business Overview
    • 11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Johnson & Johnson Anti-inflammatory Drugs Products Offered
    • 11.3.5 Johnson & Johnson Related Developments
  • 11.4 Merck & Co.
    • 11.4.1 Merck & Co. Corporation Information
    • 11.4.2 Merck & Co. Description and Business Overview
    • 11.4.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Merck & Co. Anti-inflammatory Drugs Products Offered
    • 11.4.5 Merck & Co. Related Developments
  • 11.5 Pfizer
    • 11.5.1 Pfizer Corporation Information
    • 11.5.2 Pfizer Description and Business Overview
    • 11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Pfizer Anti-inflammatory Drugs Products Offered
    • 11.5.5 Pfizer Related Developments
  • 11.6 Amgen
    • 11.6.1 Amgen Corporation Information
    • 11.6.2 Amgen Description and Business Overview
    • 11.6.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Amgen Anti-inflammatory Drugs Products Offered
    • 11.6.5 Amgen Related Developments
  • 11.7 Sanofi
    • 11.7.1 Sanofi Corporation Information
    • 11.7.2 Sanofi Description and Business Overview
    • 11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Sanofi Anti-inflammatory Drugs Products Offered
    • 11.7.5 Sanofi Related Developments
  • 11.8 Novartis
    • 11.8.1 Novartis Corporation Information
    • 11.8.2 Novartis Description and Business Overview
    • 11.8.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Novartis Anti-inflammatory Drugs Products Offered
    • 11.8.5 Novartis Related Developments
  • 11.9 Eli Lilly
    • 11.9.1 Eli Lilly Corporation Information
    • 11.9.2 Eli Lilly Description and Business Overview
    • 11.9.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Eli Lilly Anti-inflammatory Drugs Products Offered
    • 11.9.5 Eli Lilly Related Developments
  • 11.10 Amgen
    • 11.10.1 Amgen Corporation Information
    • 11.10.2 Amgen Description and Business Overview
    • 11.10.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Amgen Anti-inflammatory Drugs Products Offered
    • 11.10.5 Amgen Related Developments
  • 11.1 Roche
    • 11.1.1 Roche Corporation Information
    • 11.1.2 Roche Description and Business Overview
    • 11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Roche Anti-inflammatory Drugs Products Offered
    • 11.1.5 Roche Related Developments
  • 11.12 Novacap
    • 11.12.1 Novacap Corporation Information
    • 11.12.2 Novacap Description and Business Overview
    • 11.12.3 Novacap Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Novacap Products Offered
    • 11.12.5 Novacap Related Developments
  • 11.13 Kopran Ltd.
    • 11.13.1 Kopran Ltd. Corporation Information
    • 11.13.2 Kopran Ltd. Description and Business Overview
    • 11.13.3 Kopran Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Kopran Ltd. Products Offered
    • 11.13.5 Kopran Ltd. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Anti-inflammatory Drugs Market Estimates and Projections by Region
    • 12.1.1 Global Anti-inflammatory Drugs Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Anti-inflammatory Drugs Revenue Forecast by Regions 2021-2026
  • 12.2 North America Anti-inflammatory Drugs Market Size Forecast (2021-2026)
    • 12.2.1 North America: Anti-inflammatory Drugs Sales Forecast (2021-2026)
    • 12.2.2 North America: Anti-inflammatory Drugs Revenue Forecast (2021-2026)
    • 12.2.3 North America: Anti-inflammatory Drugs Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Anti-inflammatory Drugs Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Anti-inflammatory Drugs Sales Forecast (2021-2026)
    • 12.3.2 Europe: Anti-inflammatory Drugs Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Anti-inflammatory Drugs Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Anti-inflammatory Drugs Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Anti-inflammatory Drugs Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Anti-inflammatory Drugs Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Anti-inflammatory Drugs Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Anti-inflammatory Drugs Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Anti-inflammatory Drugs Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Anti-inflammatory Drugs Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Anti-inflammatory Drugs Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Anti-inflammatory Drugs Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Anti-inflammatory Drugs Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Anti-inflammatory Drugs Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Anti-inflammatory Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Anti-inflammatory Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Anti-inflammatory Drugs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Anti-inflammatory Drugs. Industry analysis & Market Report on Anti-inflammatory Drugs is a syndicated market report, published as Global Anti-inflammatory Drugs Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Anti-inflammatory Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,014.70
    4,522.05
    6,029.40
    3,630.90
    5,446.35
    7,261.80
    595,491.00
    893,236.50
    1,190,982.00
    329,160.00
    493,740.00
    658,320.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report